What Does the Historical and Current Enteral Stents Market Size Trend Indicate?
The enteral stents market has seen considerable growth due to a variety of factors.
• In recent times, the enteral stents market has experienced significant growth. The market is projected to expand from $1.44 billion in 2024 to $1.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.9%.
The growth during this historical period can be traced back to advancements in endoscopic procedures, supportive reimbursement policies, increased surgical success rates, regulatory approvals, and a heightened understanding of GI treatments.
What Is the Forecasted Market Size and Growth Rate for The Enteral Stents Market?
The enteral stents market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a robust expansion is anticipated in the enteral stents market. The value of the market is predicted to reach $2.08 billion by the end of 2029, showing a compound annual growth rate (CAGR) of 7.6%.
This growth during the projected period is due to factors such as the emphasis on better quality of life, advancements in biocompatibility studies, sustainable manufacturing processes, an increase in healthcare insurance coverage, and the implementation of value-based healthcare. Emerging trends to watch within this period include the development of new-generation biodegradable stents, AI-based customized stents, bioactive stents, stents enabled with wireless communication, and the application of CRISPR in drug delivery.
What Are The Primary Growth Drivers In The Enteral Stents Market?
The escalating occurrence of gastrointestinal disorders is anticipated to boost the expansion of the enteral stents market. Such disorders encompass a variety of conditions affecting the gastrointestinal tract, including the esophagus, stomach, intestines, and related organs, yielding symptoms like discomfort and pain. Poor eating habits, heightened stress, sedentary lifestyles, excessive antibiotic usage and escalated exposure to environmental toxins have led to an increased prevalence of these disorders. Enteral stents play a crucial role in managing these disorders, providing a less invasive solution to alleviate blockages, restore normal food and fluid flow, and enhance overall digestion. Consequently, they enhance patient comfort and quality of life. For example, in June 2023, based on data from Crohn’s and Colitis Canada, a nonprofit organization in Canada, it is estimated that in 2023, about 0.8% of the population, or 322,600 Canadians, lived with IBD. Predictions indicate that this number could surge to 470,000, or 1.1% of the population, by 2035. Hence, the escalating occurrence of gastrointestinal disorders is fuelling the growth of the enteral stent market. An increased incidence of cancer is anticipated to fuel the growth of the enteral stents market. Cancers encompass a group of diseases typified by the unchecked proliferation and dissemination of abnormal cells in the body. The increased incidence of cancer is attributed to an aging population, lifestyle factors, superior diagnostic techniques, genetic predisposition, and improved access and awareness of healthcare. Enteral stents are deployed to alleviate obstructions in the gastrointestinal system caused by cancer, thereby enhancing symptoms like dysphagia and preserving nutrient intake. In February 2024, as per the data from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, it is projected that by 2050, over 35 million new cancer cases will be registered, a 77% increase from the projected 20 million cases in 2022. Therefore, the rising prevalence of cancer is fuelling the growth of the enteral stents market.
What Key Areas Define The Segmentation Of The Global Enteral Stents Market?
The enteral stents market covered in this report is segmented –
1) By Stent Type: Esophageal Stents, Gastroduodenal Stents, Colon Stents
2) By Material Type: Self-Expandable Plastic Stents, Self-Expandable Metal Stents
3) By End User: Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers
Subsegments:
1) By Esophageal Stents: Self-Expanding Metal Esophageal Stents, Covered Esophageal Stents, Uncovered Esophageal Stents, Hybrid Esophageal Stents, Temporary Esophageal Stents
2) By Gastroduodenal Stents: Self-Expanding Metal Gastroduodenal Stents, Covered Gastroduodenal Stents, Uncovered Gastroduodenal Stents, Biodegradable Gastroduodenal Stents
3) By Colon Stents: Self-Expanding Metal Colon Stents, Covered Colon Stents, Uncovered Colon Stents, Biodegradable Colon Stents, Colon Stents For Colonic Obstruction
Pre-Book The Enteral Stents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players in the Enteral Stents Market?
Major companies operating in the enteral stents market are include:
• Cardinal Health Inc.
• Medtronic Inc.
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• AMETEK Inc.
• Lepu Medical Technology (Beijing) Co Ltd.
• Endo-Therapeutics Inc.
• Cook Medical
• Micro-Tech (Nanjing) Co Ltd.
• Merit Medical Systems Inc.
• ConMed Corporation
• GBUK Group Ltd.
• Biosensors International Group Ltd.
• Medi-Globe GmbH
• BVM Medical Limited
• Taewoong Medical Inc.
• ELLA-CS s.r.o.
• Mitra Industries Inc.
• Hobbs Medical Inc.
What Is The Most Dominant Region In The Enteral Stents Market?
North America was the largest region in the enteral stents market in 2024. The regions covered in the enteral stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
